Liver transplantation for hepatocellular carcinoma

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 15, Issue 2, 2008, Pages 124-130

  Taketomi, Akinobu ^a   Soejima, Yuji ^a   Yoshizumi, Tomoharu ^a   Uchiyama, Hideaki ^a   Yamashita, Yo Ichi ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Living donor; Predictive factor; Recurrence

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; IMMUNOSUPPRESSIVE AGENT;

CADAVER DONOR; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CHEMOEMBOLIZATION; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; PREDICTION; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; TREATMENT OUTCOME; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING;

EID: 42049083167     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-007-1296-4     Document Type: Review

References (52)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-2576.
2. Okita K. Clinical aspects of hepatocellular carcinoma in Japan. Intern Med 2006;45:229-233.
3. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
4. Takenaka K, Yamamoto K, Taketomi A, Itasaka H, Adachi E, Shirabe K, et al. A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma. Hepatology 1995;22:20-24.
5. Lovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005;25:181-200.
6. Schwartz M, Roayaie S, Konstadoulakis M. Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol 2007;4:424-432.
7. O'Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 1988;207:373-379.
8. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients. World J Surg 1991;15:270-285.
9. Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991;214:221-228.
10. Mazzaferro V, Regalia E, Doci R, Andreola R, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinoma. N Engl J Med 1996;334:693-699.
11. United Network for Organ Sharing, Policy 3.6. Available at: http://www.unos.org/policiesandbylaws/policies.asp?resources=true. Accessed October 26, 2007.
12. Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy. Gastroenterology 2004;127(Suppl):S261-S267.
13. Todo S, Furukawa H; on behalf of the Japan Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular caricnoma: Experience in Japan. Ann Surg 2004;240:451-461.
14. Benckert C, Jonas S, Thelen A, Spinelli A, Schumacher G, Heise M, et al. Liver transplantation for hepatocellular carcinoma in cirrhosis: prognostic parameters. Transplant Proc 2005;37:1693-1694.
15. Kim YS, Lim HK, Rhim H, Lee WJ, Joh JW, Park CK, et al. Recurrence of hepatocellular carcinoma after liver transplantation: Patterns and prognostic factors based on clinical and radiologic features. AJR Am J Roentgenol 2007;189:352-382.
16. Hemming AW, Cattral MS, Reed AI, Van Der Werf WJ, Greig PD, Howard RJ. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001;233:652-659.
17. Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, et al. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Liver Transpl 2007;13:807-813.
18. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: A registry report of the impact of tumor characteristics on outcome. Ann Surg 1998;228:479-490.
19. Hwang S, Lee SG, Joh JW, Suh KS, Kim DG. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: Comparison between cadaveric donor and living donor liver trasnplantation. Liver Transpl 2005;11:1265-1272.
20. Unitt E, Marshall A, Gelson W, Rushbrook SM, Davies S, Vowler SL, et al. Tumor lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol 2006;45:246-253.
21. Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Aishima S, Terashi T, et al. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation 2007;83:893-899.
22. Takada Y, Ito T, Ueda M, Sakamoto S, Haga H, Maetani Y, et al. Living donor liver transplantation for patients with HCC exceeding the Mila criteria: A proposal of expanded criteria. Dig Dis 2007;25:299-302.
23. Shimada M, Yonemura Y, Ijichi H, Harada N, Shiotani S, Ninomiya M, et al. Living donor liver transplantation for hepatocellular carcinoma: A special reference to a preoperative desgamma-carboxy prothrombin value. Transplant Proc 2005;37:1177-1179.
24. Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, et al. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients. Hepatology 2003;37:1114-1121.
25. Shirabe K, Itoh S, Yoshizumi T, Soejima Y, Taketomi A, Aishima S, et al. The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol 2007;95:235-240.
26. Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, et al. Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: A prospective analysis of 227 patients. Cancer 2001;91:561-569.
27. Suzuki M, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Nakanishi Y, et al. Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma. J Biol Chem 2005;280:6409-6415.
28. Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, et al. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma Liver Transpl 2005;11:767-775.
29. Ravaioli M, Grazi GL, Ercolani G, Fiorentino M, Cescon M, Golfieri R et al. Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. Transplantation 2004;78:1780-1786.
30. Liou TC, Shih SC, Kao CR, Chou SY, Lin SC, Wang HY. Pulmonary metastasis of hepatocellular carcinoma associated with transarterial chemoembolization. J Hepatol 1995;23:563-568.
31. Bharat A, Brown DB, Crippin JS, Gould JE, Lowell JA, Shenoy S, et al. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg 2006;203:411-420.
32. Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R Jr, Kerlan R, et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transpl 2005;5:795-804.
33. Millonig G, Graziadei IW, Freund MC, Jaschke W, Stadlmann S, Ladurner R, et al. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2007;13:272-279.
34. Lu DS, Yu NC, Raman SS, Lassman C, Tong MJ, Britten C, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005;41:1130-1137.
35. Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: A prospective study. Ann Surg 2004;240:900-909.
36. Kawasaki S, Makuuchi M, Matsunami H, Hashikura Y, Ikegami T, Nakazawa Y, et al. Living related liver transplantation in adults. Ann Surg 1998;227:269-274.
37. Cheng SJ, Pratt DS, Freeman RB Jr, Kaplan MM, Wong JB. Living-donor versus cadaveric liver transplantation for nonresectable small hepatocellular carinoma and compensated cirrhosis: A decision analysis. Transplantation 2001;72:861-868.
38. Sarasin FP, Majno PE, Llovet JM, Bruix J, Mentha G, Hadengue A. Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective. Hepatology 2001;33:1073-1079.
39. Lo CM, Fan ST, Liu CL, Chan SC, Wong J. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 2004;10:440-447.
40. Furukawa H, Shimamura T, Suzuki T, Taniguchi M, Yamashita K, Kamiyama T, et al. Living-donor liver transplantation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2006;13:393-397.
41. Fisher RA, Kulik LM, Freise CE, Lok ASF, Shearon TH, Brown RS Jr, et al. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transpl 2007;7:1601-1608.
42. Hwang S, Lee SG, Ahn CS, Kim KH, Moon DB, Ha TY, et al. Small-size liver graft does not increase the risk of hepatocellular carcinoma recurrence after living donor liver transplantation. Transplant Proc 2007;39:1526-1529.
43. Efimova EA, Glanemann M, Liu L, Schumacher G, Settmacher U, Jonas SE, et al. Effects of human hepatocyte growth factor on the proliferation of human hepatocytes and hepatocellular carcinoma cell lines. Eur Surg Res 2004;36:300-307.
44. Florman S, Miller C. Live donor liver transplantation. Liver Transpl 2006;14:499-510.
45. Bramstedt K. Living liver donor mortality: Where do we stand? Am J Gastroenterol 2006;101:755-759.
46. Chan SC, Fan ST, Lo CM, Liu CL, Wong J. Towards current standards of donor right hepatectomy for adult-to-adult liver donor liver transplantation through the experience of 200 cases. Ann Surg 2007;245:110-117.
47. Kokudo N, Sugawara Y, Imamura H, Sano K, Makuuchi M. Tailoring type of donor hepatectomy for adult living donor liver transplantation. Am J Transpl 2005;5:1694-1703.
48. Hwang S, Lee SG, Lee YJ, Sung KB, Park KM, Kim KH, et al. Lessons learned from 1000 living donor liver transplantations in a single center: How to make living donations safe. Liver Transpl 2006;12:920-927.
49. Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, et al. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 2005;100:2708-2716.
50. Grasso A, Stigliano R, Morisco F, Martines H, Quaglia A, Dhillon AP, et al. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study. Transplantation 2006;81:1532-1541.
51. Merli M, Nicolini G, Gentili F, Novelli G, Iappelli M, Casciaro G, et al. Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Transplant Proc 2005;37:2535-2540.
52. Yao FY, Hirose R, LaBerge JM, Davern TJ 3rd, Bass NM, Kerlan RK Jr, et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 2005;11:1505-1514.